Nova Leap Health Corp (NLH) - Net Assets
Based on the latest financial reports, Nova Leap Health Corp (NLH) has net assets worth CA$19.04 Million CAD (≈ $13.77 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$23.48 Million ≈ $16.99 Million USD) and total liabilities (CA$4.44 Million ≈ $3.21 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible equity quality of Nova Leap Health Corp to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CA$19.04 Million |
| % of Total Assets | 81.09% |
| Annual Growth Rate | 59.53% |
| 5-Year Change | 3.04% |
| 10-Year Change | 12997.92% |
| Growth Volatility | 344.23 |
Nova Leap Health Corp - Net Assets Trend (2016–2025)
This chart illustrates how Nova Leap Health Corp's net assets have evolved over time, based on quarterly financial data. See how many days can Nova Leap Health Corp fund operations to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Nova Leap Health Corp (2016–2025)
The table below shows the annual net assets of Nova Leap Health Corp from 2016 to 2025. For live valuation and market cap data, see NLH company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CA$19.04 Million ≈ $13.77 Million |
+4.35% |
| 2024-12-31 | CA$18.25 Million ≈ $13.20 Million |
+0.29% |
| 2023-12-31 | CA$18.20 Million ≈ $13.16 Million |
-2.60% |
| 2022-12-31 | CA$18.68 Million ≈ $13.51 Million |
+1.09% |
| 2021-12-31 | CA$18.48 Million ≈ $13.37 Million |
+87.77% |
| 2020-12-31 | CA$9.84 Million ≈ $7.12 Million |
+39.13% |
| 2019-12-31 | CA$7.07 Million ≈ $5.12 Million |
+4.59% |
| 2018-12-31 | CA$6.76 Million ≈ $4.89 Million |
+271.31% |
| 2017-12-31 | CA$1.82 Million ≈ $1.32 Million |
+1152.94% |
| 2016-12-31 | CA$145.38K ≈ $105.17K |
-44.78% |
| 2016-10-31 | CA$263.28K ≈ $190.45K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Nova Leap Health Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 68748200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CA$20.10 Million | 105.56% |
| Total Equity | CA$19.04 Million | 100.00% |
Nova Leap Health Corp Competitors by Market Cap
The table below lists competitors of Nova Leap Health Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Devonian Health Group Inc
V:GSD
|
$22.43 Million |
|
Aytu BioScience Inc
NASDAQ:AYTU
|
$22.43 Million |
|
Skandia Greenpower AS
OL:SKAND
|
$22.44 Million |
|
KONG SUN (BL25000)
F:KOJ5
|
$22.45 Million |
|
Fabrity Holding S.A.
WAR:FAB
|
$22.42 Million |
|
Green Critical Minerals Ltd
AU:GCM
|
$22.41 Million |
|
Games Operators SA
WAR:GOP
|
$22.40 Million |
|
Israel Op L
TA:ISOP
|
$22.40 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nova Leap Health Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 18,248,936 to 19,042,017, a change of 793,081 (4.3%).
- Net loss of 189,864 reduced equity.
- Other factors increased equity by 982,945.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CA$-189.86K | -1.0% |
| Other Changes | CA$982.95K | +5.16% |
| Total Change | CA$- | 4.35% |
Book Value vs Market Value Analysis
This analysis compares Nova Leap Health Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.63x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 26.90x to 1.63x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | CA$0.01 | CA$0.36 | x |
| 2017-12-31 | CA$0.09 | CA$0.36 | x |
| 2018-12-31 | CA$0.14 | CA$0.36 | x |
| 2019-12-31 | CA$0.12 | CA$0.36 | x |
| 2020-12-31 | CA$0.15 | CA$0.36 | x |
| 2021-12-31 | CA$0.24 | CA$0.36 | x |
| 2022-12-31 | CA$0.24 | CA$0.36 | x |
| 2023-12-31 | CA$0.21 | CA$0.36 | x |
| 2024-12-31 | CA$0.21 | CA$0.36 | x |
| 2025-12-31 | CA$0.22 | CA$0.36 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nova Leap Health Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -1.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -0.60%
- • Asset Turnover: 1.34x
- • Equity Multiplier: 1.23x
- Recent ROE (-1.00%) is above the historical average (-49.81%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | -153.88% | -2773.97% | 0.03x | 1.99x | CA$-431.47K |
| 2016 | -336.71% | -1224.07% | 0.10x | 2.69x | CA$-504.06K |
| 2017 | -46.75% | -80.35% | 0.36x | 1.60x | CA$-1.03 Million |
| 2018 | -14.21% | -9.28% | 0.83x | 1.84x | CA$-1.64 Million |
| 2019 | -14.92% | -6.07% | 1.23x | 2.00x | CA$-1.76 Million |
| 2020 | 12.76% | 7.26% | 0.99x | 1.78x | CA$272.08K |
| 2021 | 9.53% | 8.27% | 0.79x | 1.45x | CA$-87.33K |
| 2022 | -4.47% | -2.96% | 1.18x | 1.28x | CA$-2.70 Million |
| 2023 | -5.80% | -4.03% | 1.25x | 1.15x | CA$-2.87 Million |
| 2024 | 7.55% | 5.35% | 1.15x | 1.23x | CA$-446.43K |
| 2025 | -1.00% | -0.60% | 1.34x | 1.23x | CA$-2.09 Million |
Industry Comparison
This section compares Nova Leap Health Corp's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $261,862,164
- Average return on equity (ROE) among peers: -126.41%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nova Leap Health Corp (NLH) | CA$19.04 Million | -153.88% | 0.23x | $22.42 Million |
| HealWELL AI Inc. (AIDX) | $29.75 Million | -52.68% | 1.05x | $190.97 Million |
| CareRx Corp (CRRX) | $15.82 Million | 10.36% | 1.00x | $148.37 Million |
| dentalcorp Holdings Ltd (DNTL) | $1.77 Billion | -3.35% | 0.91x | $1.52 Billion |
| Medical Facilities Corporation (DR) | $151.82 Million | -10.12% | 1.20x | $221.95 Million |
| Element Lifestyle Retirement Inc (ELM) | $617.61K | -13.15% | 0.66x | $509.83K |
| Extendicare Inc (EXE) | $353.83 Million | 5.35% | 4.10x | $2.18 Billion |
| Jack Nathan Medical Corp (JNH) | $8.52 Million | -116.33% | 0.25x | $65.46 |
| KDA Group Inc (KDA) | $840.86K | -954.38% | 36.73x | $11.96 Million |
| NeuPath Health Inc (NPTH) | $20.95 Million | -3.42% | 1.15x | $24.44 Million |
About Nova Leap Health Corp
Nova Leap Health Corp., together with its subsidiaries, provides home-based and community-based healthcare services in the United States and Canada. It offers home and home health care services, including dementia care, companionship, personal and skilled nursing care, respite care, palliative care, care management, cooking and meal preparation, light housekeeping, daily living activities, transp… Read more